<!DOCTYPE html>
<html lang="en">
<head>
<title>EGFR Mutation Detection - Real Time PCR Including T790M-USFDA Approved Kit- Price, Normal Range | Sprint Diagnostics Hyderabad</title>
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0">
<meta name="description" content="EGFR mutation detection is a diagnostic procedure that plays a critical role in the management of non-
small cell lung cancer (NSCLC). EGFR, or Epidermal Growth Factor Receptor, is a protein found on the
surface of some cells and is involved in cell growth and division. ">
<meta property="og:title" content="EGFR Mutation Detection - Real Time PCR Including T790M-USFDA Approved Kit- Price, Normal Range | Sprint Diagnostics Hyderabad" />
<meta property="og:description" content="EGFR mutation detection is a diagnostic procedure that plays a critical role in the management of non-
small cell lung cancer (NSCLC). EGFR, or Epidermal Growth Factor Receptor, is a protein found on the
surface of some cells and is involved in cell growth and division."/>
<meta property="og:image" content="" />
<meta property="og:url" content="" />
<link rel="canonical" href="" />
<!-- Schema start from here -->

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [{
    "@type": "Question",
    "name": "What is the EGFR Mutation Detection test?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "The EGFR Mutation Detection test is a diagnostic procedure used to identify mutations in the EGFR
gene, particularly in patients with non-small cell lung cancer. The test helps in determining the most
suitable targeted therapy for the patient."
    }
  },{
    "@type": "Question",
    "name": "What does a positive result mean?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "A positive result means that a mutation in the EGFR gene has been detected. This information can be
used to guide treatment decisions, such as the use of targeted therapies."
    }
  },{
    "@type": "Question",
    "name": "What factors could affect the test results?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "The quality of the sample, the stage of cancer, and the presence of other mutations or genetic variations
can affect the test results."
    }
  }]
}
</script>


<script type="application/ld+json">
{
  "@context": "https://schema.org/", 
  "@type": "BreadcrumbList", 
  "itemListElement": [{
    "@type": "ListItem", 
    "position": 1, 
    "name": "Home page",
    "item": "https://www.sprintdiagnostics.in"  
  },{
    "@type": "ListItem", 
    "position": 2, 
    "name": "Test",
    "item": "https://www.sprintdiagnostics.in/hyderabad/test/"  
  },{
    "@type": "ListItem", 
    "position": 3, 
    "name": "EGFR Mutation Detection - Real Time PCR",
    "item": "https://www.sprintdiagnostics.in/hyderabad/test/egfr-mutation-detection-real-time-pcr-including-t790m-usfda-approved-kit"  
  }]
}
</script>

<!-- Schema end here -->
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>EGFR Mutation Detection - Real Time PCR (Exon 18, 19, 20, 21) Including T790M-USFDA Approved Kit </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">EGFR Mutation Detection - Real Time PCR (Exon 18, 19, 20, 21) Including T790M-USFDA Approved Kit  </h1>
<div class="post-text">
<p>EGFR mutation detection is a diagnostic procedure that plays a critical role in the management of non-
small cell lung cancer (NSCLC). EGFR, or Epidermal Growth Factor Receptor, is a protein found on the
surface of some cells and is involved in cell growth and division. Mutations in the EGFR gene can cause
the receptor to malfunction, leading to the uncontrolled growth of cancer cells. The EGFR Mutation
Detection test using Real Time PCR for Exon 18, 19, 20, 21 including T790M, is an FDA-approved assay
that aids in identifying these mutations, thereby guiding the most effective treatment approach. </p>
<p>The test is performed on tumor tissue samples obtained through a biopsy or blood samples. It is
designed to detect specific mutations in the EGFR gene, particularly in Exon 18, 19, 20, and 21, which are
common in non-small cell lung cancer. Among these, the T790M mutation is especially significant as it is
associated with resistance to certain EGFR-targeting therapies. </p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">EGFR Mutation Detection - Real Time PCR (Exon 18, 19, 20, 21) Including T790M-USFDA Approved Kit  </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Tumor Tissue.</td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>For tissue samples, follow your doctor's instructions regarding biopsy procedures. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>7 days </td>
		</tr>
		<tr>
			<th scope="row">Price</th>
			<td>â‚¹ 8500 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
	<h2 class="test-h2 mt-3">What is the EGFR Mutation Detection test? </h2>
	<p>The EGFR Mutation Detection test is a diagnostic procedure used to identify mutations in the EGFR
gene, particularly in patients with non-small cell lung cancer. The test helps in determining the most
suitable targeted therapy for the patient. </p>
	<h2 class="test-h2 mt-3">Why is detecting EGFR mutations important in non-small cell lung cancer (NSCLC)? </h2>
	<p>EGFR mutations are common in NSCLC and their presence can influence the progression of the disease
and response to therapy. Detecting these mutations helps in selecting the most appropriate targeted
therapy, which can be more effective and have fewer side effects than conventional chemotherapy. </p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	<h2 class="test-h2 mt-3">What are Exons 18, 19, 20, and 21, and why are they significant? </h2>
	<p>Exons 18, 19, 20, and 21 are regions of the EGFR gene where mutations are commonly found in NSCLC.
These mutations can result in altered protein functions that contribute to cancer development and
progression. Identifying mutations in these exons can be crucial for selecting targeted therapies. </p>
	<h2 class="test-h2 mt-3">What is the T790M mutation and why is it important? </h2>
	<p>The T790M mutation is a specific change in the EGFR gene that is associated with resistance to certain
EGFR inhibitors. Detecting the T790M mutation can help in identifying patients who may benefit from
alternative treatments. </p>
	<h2 class="test-h2 mt-3">How is the EGFR Mutation Detection test performed? </h2>
	<p>The test is performed on a sample of tumor tissue or blood. The DNA is extracted and then analyzed
using Real Time PCR to detect specific mutations in the EGFR gene. </p>
	<h2 class="test-h2 mt-3">Is there any preparation needed before the test? </h2>
	<p>No specific preparation is needed for the blood sample. For tissue samples, your doctor will provide
instructions regarding the biopsy procedure. </p>
	<h2 class="test-h2 mt-3">How is this test used in guiding cancer treatment? </h2>
	<p>If mutations in the EGFR gene are detected, especially in exons 18, 19, 20, or 21, it can indicate that the
patient may benefit from targeted therapy that specifically addresses these mutations. The test also
helps in monitoring resistance to treatment, particularly in the case of the T790M mutation. </p>
	<h2 class="test-h2 mt-3">Are there any limitations to the EGFR Mutation Detection test? </h2>
	<p>Yes, the test may not detect all mutations in the EGFR gene and is mainly focused on the most common
ones associated with NSCLC. Also, a negative result does not rule out the presence of EGFR mutations
not covered by this test. </p>
	<h2 class="test-h2 mt-3">What does a positive result mean? </h2>
	<p>A positive result means that a mutation in the EGFR gene has been detected. This information can be
used to guide treatment decisions, such as the use of targeted therapies. </p>
	<h2 class="test-h2 mt-3">What factors could affect the test results? </h2>
	<p>The quality of the sample, the stage of cancer, and the presence of other mutations or genetic variations
can affect the test results. </p>
	<h2 class="test-h2 mt-3">Is the EGFR Mutation Detection test covered by insurance? </h2>
	<p>Coverage for the EGFR Mutation Detection test can vary depending on your health insurance plan. It is
recommended to check with your insurance provider for details regarding coverage. </p>
	<h2 class="test-h2 mt-3">Which doctor should I consult if I have an abnormal EGFR Mutation Detection result? </h2>
	<p>If you have an abnormal EGFR Mutation Detection result, it is important to consult an oncologist, who
specializes in cancer treatment, to discuss the implications of the results and the available treatment
options. </p>
	<h2 class="test-h2 mt-3">How often should this test be performed? </h2>
	<p>The frequency of this test should be determined by your doctor based on your health status and
response to therapy. </p>
	<h2 class="test-h2 mt-3">Are there any alternative tests to detect EGFR mutations? </h2>
	<p>Yes, there are alternative tests such as Next-Generation Sequencing (NGS) that can detect a broader
range of mutations including EGFR. </p>
	<h2 class="test-h2 mt-3">Can this test be used for cancers other than lung cancer? </h2>
	<p>Yes, though it is primarily used for NSCLC, it can also be used in other cancers where EGFR mutations
play a role. </p>
	
	<p>Understanding the genetic makeup of a tumor can be a powerful tool in battling cancer. The EGFR
Mutation Detection test provides critical information that can guide treatment decisions for patients
with non-small cell lung cancer. By identifying specific mutations, particularly in the EGFR gene, doctors
can personalize treatment plans to target the genetic changes driving the cancer, potentially leading to
more effective treatment with fewer side effects. Consultation with an oncologist is crucial for
interpreting the results and making informed treatment choices. </p>
</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>